Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.10−0.02 (-0.94%)
Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –
Compugen total assets
Total assets on the balance sheet at the end of each period.
Compugen's total assets was $138.37M at Jun 30, 2026. For fiscal 2025 it was $156.57M, up 36.2% from the year before. Over ten years it grew 4.7% a year on average. The highest annual figure on record is $156.57M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $156.57M | +36.2% |
| FY2024 | Dec 31, 2024 | $115.00M | -5.2% |
| FY2023 | Dec 31, 2023 | $121.33M | +28.8% |
| FY2022 | Dec 31, 2022 | $94.18M | -28.7% |
| FY2021 | Dec 31, 2021 | $132.16M | -4.4% |
| FY2020 | Dec 31, 2020 | $138.32M | +157.3% |
| FY2019 | Dec 31, 2019 | $53.76M | +1.1% |
| FY2018 | Dec 31, 2018 | $53.18M | +37.3% |
| FY2017 | Dec 31, 2017 | $38.75M | -45.5% |
| FY2016 | Dec 31, 2016 | $71.14M | -28.4% |
| FY2015 | Dec 31, 2015 | $99.31M | -13.6% |
| FY2014 | Dec 31, 2014 | $114.99M | +102.8% |
| FY2013 | Dec 31, 2013 | $56.71M | +96.2% |
| FY2012 | Dec 31, 2012 | $28.91M | -0.6% |
| FY2011 | Dec 31, 2011 | $29.08M | -20.2% |
| FY2010 | Dec 31, 2010 | $36.46M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $138.37M | +25.6% |
| Q4 FY2025 | Dec 31, 2025 | $156.57M | +29.0% |
| Q2 FY2025 | Jun 30, 2025 | $106.53M | +38.2% |
| Q4 FY2024 | Dec 31, 2024 | $115.00M | +22.1% |
| Q2 FY2024 | Jun 30, 2024 | $110.17M | -0.1% |
| Q4 FY2023 | Dec 31, 2023 | $121.33M | -8.2% |
| Q2 FY2023 | Jun 30, 2023 | $77.06M | -37.3% |
| Q4 FY2022 | Dec 31, 2022 | $94.18M | -31.9% |
| Q2 FY2022 | Jun 30, 2022 | $110.31M | -24.4% |
| Q4 FY2021 | Dec 31, 2021 | $132.16M | +145.8% |
| Q2 FY2021 | Jun 30, 2021 | $122.82M | +154.5% |
| Q4 FY2020 | Dec 31, 2020 | $138.32M | +160.1% |
| Q2 FY2020 | Jun 30, 2020 | $145.92M | +185.9% |
| Q4 FY2019 | Dec 31, 2019 | $53.76M | +38.8% |
| Q2 FY2019 | Jun 30, 2019 | $48.27M | -13.2% |
| Q4 FY2018 | Dec 31, 2018 | $53.18M | -25.2% |
| Q2 FY2018 | Jun 30, 2018 | $51.04M | -39.6% |
| Q4 FY2017 | Dec 31, 2017 | $38.75M | -61.0% |
| Q2 FY2017 | Jun 30, 2017 | $55.62M | -46.1% |
| Q4 FY2016 | Dec 31, 2016 | $71.14M | -38.1% |
| Q2 FY2016 | Jun 30, 2016 | $84.46M | -30.5% |
| Q4 FY2015 | Dec 31, 2015 | $99.31M | +75.1% |
| Q2 FY2015 | Jun 30, 2015 | $103.26M | +179.0% |
| Q4 FY2014 | Dec 31, 2014 | $114.99M | +297.8% |
| Q2 FY2014 | Jun 30, 2014 | $121.54M | +305.3% |
| Q4 FY2013 | Dec 31, 2013 | $56.71M | +95.0% |
| Q2 FY2013 | Jun 30, 2013 | $37.01M | +1.5% |
| Q4 FY2012 | Dec 31, 2012 | $28.91M | – |
| Q2 FY2012 | Jun 30, 2012 | $29.99M | – |
| Q4 FY2011 | Dec 31, 2011 | $29.08M | – |
| Q4 FY2010 | Dec 31, 2010 | $36.46M | – |
See a number that looks wrong?